Remternetug, Placebo to match LY3372993, PiB clinical trials

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer’s Disease

This study is testing new medicines for an early-onset, inherited form of Alzheimer's disease. Researchers want to see if these treatments can stop or slow down the disease before symptoms appear, by checking changes in the brain over time.